The ideal partner to bring your product to commercial success, offering a breadth of transdermal innovation from a depth of experience.
Aveva is a global leader in transdermal drug delivery located in the US. The company has an extensive history of providing pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents. By leveraging this experience, Aveva offers a full range of research, development and manufacturing capabilities to produce transdermal pharmaceutical products that can improve the quality of life, usage and compliance rates for patients.
Aveva uses a number of sophisticated technologies to produce proprietary and generic transdermal drug delivery systems that fortify R&D pipelines and enhance compounds by:
Commercial successes can be found in the following therapeutic categories:
Our deal configurations are designed for maximum flexibility in accordance with the needs of our partners, and are as unique to each client as our customized transdermal drug delivery systems:
At Aveva Drug Delivery Systems, we don't employ just one process in the development of transdermal drug delivery systems. We create individualized systems that are specifically designed for the chemical entity, rapidly and cost-effectively generating unique products to meet specialized needs.
We clearly recognize and understand the need for leading-edge capabilities and innovative technologies in order to open up a growing pool of new pharmaceutical compounds for transdermal drug delivery.
Aveva Drug Delivery Systems
United States of America
Tel: +1 954 624 1374 (VP business development)